Product Name

  • Name

    Calcitriol

  • EINECS 250-963-8
  • CAS No. 32222-06-3
  • Article Data55
  • CAS DataBase
  • Density 1.06 g/cm3
  • Solubility
  • Melting Point 119-121 °C
  • Formula C27H44O3
  • Boiling Point 565 °C at 760 mmHg
  • Molecular Weight 416.645
  • Flash Point 238.4 °C
  • Transport Information UN 2811 6.1/PG 1
  • Appearance white crystalline powder
  • Safety 36/37/39-45-36-26
  • Risk Codes 26/27/28-63-36/37/38-20/21/22
  • Molecular Structure Molecular Structure of 32222-06-3 (Calcitriol)
  • Hazard Symbols VeryT+,HarmfulXn
  • Synonyms U 49562;Calcitriol (JAN/USAN);(1S,3R,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol;Calcitriol [USAN:BAN:INN:JAN];Ro 215535;9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1.alpha.,3.beta,.5Z,7E)-;9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol,(1R,3a,5Z,7E)-;Calcitriolum [INN-Latin];(1alpha,3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol;Soltriol;Calcijex;Dihydroxyvitamin D3;Topitriol;1,25-(OH)2D3;1-alpha,25-Dihydroxyvitamin D3;1alpha,25-Dihydroxycholecalciferol;
  • PSA 60.69000
  • LogP 5.70470

Synthetic route

[2H]-Pre-1,25-D3
57102-09-7

[2H]-Pre-1,25-D3

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
at 80℃;100%
In acetone at 80.3℃; for 3h;26 mg
at 70℃; for 2h;
In hexane; ethyl acetate at 65℃;182 mg
In acetone at 80.3℃; Rate constant; Equilibrium constant; Thermodynamic data; var. temp.; kinetics, E(a), ΔG(excit.), ΔH(excit.), ΔS(excit.);
C30H52O3Si

C30H52O3Si

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride In tetrahydrofuran at 0 - 20℃; for 10h; Inert atmosphere;100%
(1R,3aS,7aR)-1-((R)-5-Methoxymethoxy-1,5-dimethyl-hexyl)-7a-methyl-4-[2-[(3S,5R)-2-methylene-3,5-bis-triisopropylsilanyloxy-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-octahydro-indene
873567-12-5

(1R,3aS,7aR)-1-((R)-5-Methoxymethoxy-1,5-dimethyl-hexyl)-7a-methyl-4-[2-[(3S,5R)-2-methylene-3,5-bis-triisopropylsilanyloxy-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-octahydro-indene

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride In tetrahydrofuran at 20℃; for 2h;95%
C45H86O3Si3

C45H86O3Si3

A

2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3

2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3

B

1α,25-dihydroxy-2-methylene-19-nor-vitamin D3

1α,25-dihydroxy-2-methylene-19-nor-vitamin D3

C

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
With AG 50W-X4 resin In methanol; benzene at 20℃; for 19h;A 95%
B n/a
C n/a
C51H98O3Si3

C51H98O3Si3

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride In tetrahydrofuran at 20℃; for 24h;81%
1α-[(triethylsilyl)oxy]-24-(tert-butoxycarbonyl)-25,26,27-trisnorvitamin D3 triethylsilyl ether

1α-[(triethylsilyl)oxy]-24-(tert-butoxycarbonyl)-25,26,27-trisnorvitamin D3 triethylsilyl ether

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
Stage #1: 1α-[(triethylsilyl)oxy]-24-(tert-butoxycarbonyl)-25,26,27-trisnorvitamin D3 triethylsilyl ether With methyllithium In diethyl ether at 0℃; for 0.5h;
Stage #2: With tetrabutyl ammonium fluoride In tetrahydrofuran for 0.75h; Darkness;
81%
methyllithium
917-54-4

methyllithium

1α-Hydroxy-25-oxo-27-norvitamin D3
77531-53-4

1α-Hydroxy-25-oxo-27-norvitamin D3

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
In diethyl ether at -78℃; for 0.333333h;80%
(1S),3(R)-9,10-secocholesta-5(E),7(E),10(19)-triene-1,3,25-triol
73837-24-8

(1S),3(R)-9,10-secocholesta-5(E),7(E),10(19)-triene-1,3,25-triol

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
With 9-acetylanthracene In ethanol Inert atmosphere; UV-irradiation; Cooling with ice;78%
With 9-acetylanthracene In methanol at 0℃; for 2h; Irradiation;66%
(1S),3(R)-bis<(tert-butyldimethylsilyl)oxy>-9,10-secocholesta-5(Z),7(E),10(19)-trien-25-ol
140710-96-9

(1S),3(R)-bis<(tert-butyldimethylsilyl)oxy>-9,10-secocholesta-5(Z),7(E),10(19)-trien-25-ol

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
With n-BuNF In tetrahydrofuran at 45℃; for 4h;71%
With tetrabutyl ammonium fluoride In tetrahydrofuran for 24h; Ambient temperature; in the dark; Yield given;
With camphor-10-sulfonic acid In methanol at 20℃; for 12h; desilylation;
(1R,3R)-5-{(Z)-2-[(1R,3aR,7aR)-1-((R)-5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl]-vinyl}-4-methyl-cyclohex-4-ene-1,3-diol

(1R,3R)-5-{(Z)-2-[(1R,3aR,7aR)-1-((R)-5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl]-vinyl}-4-methyl-cyclohex-4-ene-1,3-diol

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
In acetone at 80℃; for 4h;70%
7,8-cis-1α,25-dihydroxyvitamin D3
157809-60-4

7,8-cis-1α,25-dihydroxyvitamin D3

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
With 9-acetylanthracene In d(4)-methanol for 1.5h; Irradiation;67%
(1R,3aR,7aR)-4-{(E)-2-[(1S,3S,5S)-3-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-bicyclo[3.1.0]hex-1-yl]-vinyl}-1-((R)-5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ol
135446-94-5

(1R,3aR,7aR)-4-{(E)-2-[(1S,3S,5S)-3-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-bicyclo[3.1.0]hex-1-yl]-vinyl}-1-((R)-5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ol

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
With toluene-4-sulfonic acid In 1,4-dioxane; water64%
(R)-1-[(1S,3S,5R)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-2-methylene-cyclohexyl]-2-[(1R,3aS,7aR)-1-[(R)-5-(tert-butyl-dimethyl-silanyloxy)-1,5-dimethyl-hexyl]-7a-methyl-octahydro-inden-(4E)-ylidene]-ethanol
130759-99-8

(R)-1-[(1S,3S,5R)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-2-methylene-cyclohexyl]-2-[(1R,3aS,7aR)-1-[(R)-5-(tert-butyl-dimethyl-silanyloxy)-1,5-dimethyl-hexyl]-7a-methyl-octahydro-inden-(4E)-ylidene]-ethanol

A

calcitriol
32222-06-3

calcitriol

B

(1R,3S,5R)-5-{(E)-2-[(1R,7aR)-1-((R)-5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-2,3,5,6,7,7a-hexahydro-1H-inden-4-yl]-vinyl}-4-methylene-cyclohexane-1,3-diol
130760-01-9

(1R,3S,5R)-5-{(E)-2-[(1R,7aR)-1-((R)-5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-2,3,5,6,7,7a-hexahydro-1H-inden-4-yl]-vinyl}-4-methylene-cyclohexane-1,3-diol

Conditions
ConditionsYield
With hydrogen fluoride; silica gel; copper(II) sulfate 1) C6H6, 50 deg C, 1.5h, 2) MeOH, THF, r.t., 5h; Yield given. Multistep reaction;A n/a
B 57%
With hydrogen fluoride; silica gel; copper(II) sulfate 1) C6H6, 50 deg C, 1.5h, 2) MeOH, THF, r.t., 5h; Yield given. Multistep reaction;A 33%
B n/a
(1S,6R)-1-hydroxy-6-(1,3-benzodithiol-2-yloxy)-25-tetrahydropyranyloxy-3,5-cyclovitamin D3
161003-71-0

(1S,6R)-1-hydroxy-6-(1,3-benzodithiol-2-yloxy)-25-tetrahydropyranyloxy-3,5-cyclovitamin D3

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
With phosphomolybdic acid hydrate In 1,4-dioxane; water at 30℃; for 3h;30%
1α,3β,25-trihydroxycholesta-5,7-diene
61954-91-4

1α,3β,25-trihydroxycholesta-5,7-diene

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
Stage #1: 1α,3β,25-trihydroxycholesta-5,7-diene In 1,4-dioxane High-pressure mercury lamp;
Stage #2: at 100℃; Photomicroreactor; thermalmicroreactor;
8%
(i) EtOH, (UV-irradiation), (ii) (heating); Multistep reaction;
Multi-step reaction with 2 steps
1: tBuOMe / 0.92 h / -45 °C / Irradiation
2: 182 mg / ethyl acetate; hexane / 65 °C
View Scheme
Multi-step reaction with 3 steps
1: 6 mg / tBuOMe / 0.92 h / -45 °C / Irradiation
2: 25 mg / tBuOMe, fluorenone / -5 °C / Irradiation
3: 182 mg / ethyl acetate; hexane / 65 °C
View Scheme
(1R,3aR,7aR)-1-{(1R)-1,5-dimethyl-5-[(trimethylsilyl)oxy]hexyl}-7a-methyloctahydro-4H-inden-4-one
81506-41-4

(1R,3aR,7aR)-1-{(1R)-1,5-dimethyl-5-[(trimethylsilyl)oxy]hexyl}-7a-methyloctahydro-4H-inden-4-one

[(2Z)-2-[(3S,5R)-3,5-bis(tert-butyldimethylsilanyloxy)-2-methylenecyclohexylidene]ethyl]diphenylphosphine oxide
81522-68-1

[(2Z)-2-[(3S,5R)-3,5-bis(tert-butyldimethylsilanyloxy)-2-methylenecyclohexylidene]ethyl]diphenylphosphine oxide

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
With n-butyllithium 1.) THF, n-hexane, -78 deg C, 5 min, 2.) THF, n-hexane, -78 deg C, 2 h; Yield given. Multistep reaction;
<1R-<1α(R*),3aβ,4α<(E)-(1S*,3S*,5R*)>,7aα>>-octahydro-4-hydroxy-4-<2-(3-hydroxy-2-methylenebicyclo<3.1.0>hexan-1-yl)ethenyl>-α,α,ε-tetramethyl-1H-indene-pentanol
135041-06-4

<1R-<1α(R*),3aβ,4α<(E)-(1S*,3S*,5R*)>,7aα>>-octahydro-4-hydroxy-4-<2-(3-hydroxy-2-methylenebicyclo<3.1.0>hexan-1-yl)ethenyl>-α,α,ε-tetramethyl-1H-indene-pentanol

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
With toluene-4-sulfonic acid 1.) dioxan, water; 2.) t-butylmethyl ether, irradiation; Yield given. Multistep reaction;
With tert-butyl methyl ether; 9-acetoxyanthracene; toluene-4-sulfonic acid 1.) dioxane, H2O, 75 deg C, 4 h, 2.) irradiation, 1 h; Yield given. Multistep reaction;
anti-3-(tertbutyldimethylsiloxy)-5-(tert-butyldiphenylsiloxy)-1-octen-7-yne
138924-21-7

anti-3-(tertbutyldimethylsiloxy)-5-(tert-butyldiphenylsiloxy)-1-octen-7-yne

(E)-(20R)-de-A,B-8-(bromomethylene)cholestan-25-ol
143705-63-9

(E)-(20R)-de-A,B-8-(bromomethylene)cholestan-25-ol

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
With tris(dibenzylideneacetone)dipalladium(0) chloroform complex; tetrabutyl ammonium fluoride; thiamine diphosphate; triethylamine 1.) toluene, reflux, 2 h, 2.) THF, RT, 30 h; Yield given. Multistep reaction;
(3bR,5aR,6R,8aR,10S)-10-((3S,5R)-3,5-Dihydroxy-2-methyl-cyclohex-1-enyl)-6-((R)-5-hydroxy-1,5-dimethyl-hexyl)-5a-methyl-2-phenyl-4,5,5a,6,7,8,8a,10-octahydro-3bH-2,3a,10a-triaza-dicyclopenta[a,f]naphthalene-1,3-dione
86307-44-0

(3bR,5aR,6R,8aR,10S)-10-((3S,5R)-3,5-Dihydroxy-2-methyl-cyclohex-1-enyl)-6-((R)-5-hydroxy-1,5-dimethyl-hexyl)-5a-methyl-2-phenyl-4,5,5a,6,7,8,8a,10-octahydro-3bH-2,3a,10a-triaza-dicyclopenta[a,f]naphthalene-1,3-dione

A

calcitriol
32222-06-3

calcitriol

B

[2H]-Pre-1,25-D3
57102-09-7

[2H]-Pre-1,25-D3

Conditions
ConditionsYield
With potassium hydroxide In methanol; water at 85℃; for 70h;A 51 mg
B 9 mg
(3-bromo-1,1-dimethylpropoxy)triethylsilane
87417-12-7

(3-bromo-1,1-dimethylpropoxy)triethylsilane

1α,3β-bis<(triethylsilyl)oxy>-20(S)-<<(p-tolylsulfonyl)oxy>methyl>-9,10-secopregna-5(Z),7(E),10(19)-triene
87417-31-0

1α,3β-bis<(triethylsilyl)oxy>-20(S)-<<(p-tolylsulfonyl)oxy>methyl>-9,10-secopregna-5(Z),7(E),10(19)-triene

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
With copper(l) iodide; tetrabutyl ammonium fluoride; magnesium Yield given. Multistep reaction;
3β-tert-butyldimethylsilyl-1α-tert-butyldimethylsilyloxy-25-trimethylsilyloxy-19-norvitamin D3
599165-21-6

3β-tert-butyldimethylsilyl-1α-tert-butyldimethylsilyloxy-25-trimethylsilyloxy-19-norvitamin D3

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride In tetrahydrofuran at 25℃; Yield given;
With tetrabutyl ammonium fluoride In tetrahydrofuran
With tetrabutyl ammonium fluoride In tetrahydrofuran at 20℃; for 24h;68.3 mg
1-Oxo-25-hydroxyprevitamin D3
66760-28-9

1-Oxo-25-hydroxyprevitamin D3

A

calcitriol
32222-06-3

calcitriol

B

[2H]-Pre-1,25-D3
57102-09-7

[2H]-Pre-1,25-D3

Conditions
ConditionsYield
With sodium tris(acetoxy)borohydride; acetic acid In tetrahydrofuran for 2h; Ambient temperature;A 2.4 mg
B 11.4 mg
((5Z,7E,1S,3R)-1,25-Dihydroxy-9,10-seco-5,7,10(19)-cholestatrien-3-yl)-β-D-glucopyranosid

((5Z,7E,1S,3R)-1,25-Dihydroxy-9,10-seco-5,7,10(19)-cholestatrien-3-yl)-β-D-glucopyranosid

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
With β-glucosidase In water for 24h; Ambient temperature; formation of aglycone;
2-{(1S,5R)-5-(tert-Butyl-dimethyl-silanyloxy)-3-[2-[(1R,3aS,7aR)-1-((R)-1,5-dimethyl-5-trimethylsilanyloxy-hexyl)-7a-methyl-octahydro-inden-(4E)-ylidene]-eth-(Z)-ylidene]-2-methylene-cyclohexyloxy}-tetrahydro-pyran

2-{(1S,5R)-5-(tert-Butyl-dimethyl-silanyloxy)-3-[2-[(1R,3aS,7aR)-1-((R)-1,5-dimethyl-5-trimethylsilanyloxy-hexyl)-7a-methyl-octahydro-inden-(4E)-ylidene]-eth-(Z)-ylidene]-2-methylene-cyclohexyloxy}-tetrahydro-pyran

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
With camphor-10-sulfonic acid In methanol; water at 30℃; for 6h;
vitamin D3
67-97-0

vitamin D3

A

2alpha,25-Dihydroxyvitamin D3

2alpha,25-Dihydroxyvitamin D3

B

calcitriol
32222-06-3

calcitriol

C

calcidiol
19356-17-3

calcidiol

Conditions
ConditionsYield
With Pseudonocardia autotrophica 100U-19 cells In ethanol at 30℃; for 72h;A 35 mg
B n/a
C n/a
de-A,B-25-[(methoxymethyl)oxy]-cholestan-8-one
873567-08-9

de-A,B-25-[(methoxymethyl)oxy]-cholestan-8-one

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: t-BuLi / diethyl ether; pentane / 0.5 h / -78 °C
1.2: ZnBr2 / tetrahydrofuran; diethyl ether; pentane / -78 - -10 °C
1.3: 75 percent / Et3N / (Ph3P)4Pd / tetrahydrofuran; diethyl ether; pentane / -40 - 20 °C
2.1: 95 percent / n-Bu4NF / tetrahydrofuran / 2 h / 20 °C
View Scheme
Grundmann's alcohol
33813-99-9

Grundmann's alcohol

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: 95 percent / (trifluoromethyl)methyldioxirane / CH2Cl2 / 2 h / -20 °C
2.1: 96 percent / i-Pr2NEt; DMAP / CH2Cl2 / 24 h / 20 °C
3.1: HMDS / tetrahydrofuran / 2 h / -60 °C
3.2: 60 percent / tetrahydrofuran / 17 h / -60 - -5 °C
4.1: t-BuLi / diethyl ether; pentane / 0.5 h / -78 °C
4.2: ZnBr2 / tetrahydrofuran; diethyl ether; pentane / -78 - -10 °C
4.3: 75 percent / Et3N / (Ph3P)4Pd / tetrahydrofuran; diethyl ether; pentane / -40 - 20 °C
5.1: 95 percent / n-Bu4NF / tetrahydrofuran / 2 h / 20 °C
View Scheme
(1R,3aR,7aR)-1-[(2R)-6-hydroxy-6-methylhept-2-yl]-7a-methyloctahydroinden-4-one
70550-73-1

(1R,3aR,7aR)-1-[(2R)-6-hydroxy-6-methylhept-2-yl]-7a-methyloctahydroinden-4-one

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: 96 percent / i-Pr2NEt; DMAP / CH2Cl2 / 24 h / 20 °C
2.1: HMDS / tetrahydrofuran / 2 h / -60 °C
2.2: 60 percent / tetrahydrofuran / 17 h / -60 - -5 °C
3.1: t-BuLi / diethyl ether; pentane / 0.5 h / -78 °C
3.2: ZnBr2 / tetrahydrofuran; diethyl ether; pentane / -78 - -10 °C
3.3: 75 percent / Et3N / (Ph3P)4Pd / tetrahydrofuran; diethyl ether; pentane / -40 - 20 °C
4.1: 95 percent / n-Bu4NF / tetrahydrofuran / 2 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: 1.) sodium hexamethyldisilazide / 1.) THF, -60 deg C, 1 h, 2.) THF, RT, 30 min
2: 1.) (dba)3Pd2*CHCl3, TPP, Et3N, 2.) TBAF / 1.) toluene, reflux, 2 h, 2.) THF, RT, 30 h
View Scheme
Multi-step reaction with 2 steps
1: 98 percent / CH2Cl2 / 18 h / Ambient temperature
2: 1.) n-BuLi / 1.) THF, n-hexane, -78 deg C, 5 min, 2.) THF, n-hexane, -78 deg C, 2 h
View Scheme
Multi-step reaction with 3 steps
1: 98 percent / tetrahydrofuran / 25 °C
2: tetrahydrofuran / 1 h / -78 °C
3: (Bu)4NF / tetrahydrofuran / 25 °C
View Scheme
(1R,6R,7R)-7-[(R)-6-(methoxymethoxy)-6-methylheptan-2-yl]-6-methylbicyclo[4.3.0]nonan-2-one
139619-80-0

(1R,6R,7R)-7-[(R)-6-(methoxymethoxy)-6-methylheptan-2-yl]-6-methylbicyclo[4.3.0]nonan-2-one

calcitriol
32222-06-3

calcitriol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: HMDS / tetrahydrofuran / 2 h / -60 °C
1.2: 60 percent / tetrahydrofuran / 17 h / -60 - -5 °C
2.1: t-BuLi / diethyl ether; pentane / 0.5 h / -78 °C
2.2: ZnBr2 / tetrahydrofuran; diethyl ether; pentane / -78 - -10 °C
2.3: 75 percent / Et3N / (Ph3P)4Pd / tetrahydrofuran; diethyl ether; pentane / -40 - 20 °C
3.1: 95 percent / n-Bu4NF / tetrahydrofuran / 2 h / 20 °C
View Scheme
calcitriol
32222-06-3

calcitriol

4-<2-(6,7-dimethoxy-4-methyl-3-oxo-3,4-dihydroquinoxalyl)ethyl>-1,2,4-triazoline-3,5-dione
132788-52-4

4-<2-(6,7-dimethoxy-4-methyl-3-oxo-3,4-dihydroquinoxalyl)ethyl>-1,2,4-triazoline-3,5-dione

C42H59N5O8
132788-59-1

C42H59N5O8

Conditions
ConditionsYield
In dichloromethane Ambient temperature;100%
calcitriol
32222-06-3

calcitriol

6,7-Dimethoxy-4-methyl-3-oxo-3,4-dihydro-quinoxaline-2-carboxylic acid 4-(3,5-dioxo-3,5-dihydro-[1,2,4]triazol-4-yl)-benzyl ester
132788-51-3

6,7-Dimethoxy-4-methyl-3-oxo-3,4-dihydro-quinoxaline-2-carboxylic acid 4-(3,5-dioxo-3,5-dihydro-[1,2,4]triazol-4-yl)-benzyl ester

C48H61N5O10
132788-58-0

C48H61N5O10

Conditions
ConditionsYield
Ambient temperature;100%
calcitriol
32222-06-3

calcitriol

1-Oxo-25-hydroxyprevitamin D3
66760-28-9

1-Oxo-25-hydroxyprevitamin D3

Conditions
ConditionsYield
With Dess-Martin periodane In acetonitrile for 2h; Ambient temperature;88%
calcitriol
32222-06-3

calcitriol

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

(1S),3(R)-bis<(tert-butyldimethylsilyl)oxy>-9,10-secocholesta-5(Z),7(E),10(19)-trien-25-ol
140710-96-9

(1S),3(R)-bis<(tert-butyldimethylsilyl)oxy>-9,10-secocholesta-5(Z),7(E),10(19)-trien-25-ol

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide at 20℃; for 1h;80%
calcitriol
32222-06-3

calcitriol

N-(benzo-15-crown-5)-1,2,4-triazole-3,5-dione

N-(benzo-15-crown-5)-1,2,4-triazole-3,5-dione

C43H63N3O10

C43H63N3O10

Conditions
ConditionsYield
In ethyl acetate at 25℃;45%
calcitriol
32222-06-3

calcitriol

[2H]-Pre-1,25-D3
57102-09-7

[2H]-Pre-1,25-D3

Conditions
ConditionsYield
In acetone at 80.3℃; Equilibrium constant; var. temp.;
In benzene-d6 at 80℃; Rate constant;
Multi-step reaction with 2 steps
1: 88 percent / Dess-Martin reagent / acetonitrile / 2 h / Ambient temperature
2: 11.4 mg / sodium triacetoxyborohydride, AcOH / tetrahydrofuran / 2 h / Ambient temperature
View Scheme
calcitriol
32222-06-3

calcitriol

(4S,6R)-1-[(1R,3aS,7aR)-1-((R)-5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-(4E)-ylidenemethyl]-2,2-dioxo-2,3,4,5,6,7-hexahydro-1H-2λ6-benzo[c]thiophene-4,6-diol
140710-95-8

(4S,6R)-1-[(1R,3aS,7aR)-1-((R)-5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-(4E)-ylidenemethyl]-2,2-dioxo-2,3,4,5,6,7-hexahydro-1H-2λ6-benzo[c]thiophene-4,6-diol

Conditions
ConditionsYield
With sulfur dioxide for 1h; Heating;
With sulfur dioxide In dichloromethane at -15℃; for 3h; Yield given;
calcitriol
32222-06-3

calcitriol

1α,25-dihydroxy-6,19-dihydro-6,19-epidioxyvitamin D3

1α,25-dihydroxy-6,19-dihydro-6,19-epidioxyvitamin D3

Conditions
ConditionsYield
With oxygen; rose bengal In ethanol for 1.5h; Irradiation; Yield given;

Calcitriol Specification

1. Introduction of Calcitriol
Calcitriol is one kind of white or off-white crystalline powder. The IUPAC Name of it is (1R,5Z)-5-[(2E)-2-[(1R,7aR)-1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol. Calcitriol belongs to Miscellaneous Biochemicals;Vitamin D3 analogs;API;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals. The Classification Code of it is Bone Density Conservation Agents; Calcium channel agonists; Cardiovascular Agents; Drug / Therapeutic Agent; Growth Substances; Membrane Transport Modulators; Micronutrients; Mutation data; Regulator [calcium]; Reproductive Effect; Vasoconstrictor Agents; Vitamins.

2. Properties of Calcitriol
Physical properties about Calcitriol are:
(1)Empirical Formula: C27H44O3; (2)H bond acceptors: 3; (3)H bond donors: 3; (4)Freely Rotating Bonds: 9; (5)Polar Surface Area: 27.69 Å2; (6)Index of Refraction: 1.547; (7)Molar Refractivity: 124.35 cm3; (8)Molar Volume: 391.8 cm3; (9)Surface Tension: 44 dyne/cm; (10)Density: 1.06 g/cm3; (11)Flash Point: 238.4 °C; (12)Enthalpy of Vaporization: 97.51 kJ/mol; (13)Boiling Point: 565 °C at 760 mmHg; (14)Vapour Pressure: 4.05E-15 mmHg at 25°C; (15)CAS Registry Number: 32222-06-3; (16)Melting point: 119-121°C; (17)Storage temp: 2-8°C.

3. Structure Descriptors of Calcitriol
(1)InChI: InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18?,22-,23-,24?,25?,27-/m1/s1
(2)InChIKey: InChIKey=GMRQFYUYWCNGIN-QKIYYVKWSA-N
(3)Smiles: CC(CCCC(C)(C)O)[C@H]1CCC\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CC(C3=C)O)O)C

4. Toxicity of Calcitriol

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 1900ug/kg (1.9mg/kg) SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE

BEHAVIORAL: ATAXIA
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 11, Pg. 4175, 1983.
mouse LD50 oral 1350ug/kg (1.35mg/kg) BEHAVIORAL: ATAXIA

SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 11, Pg. 4175, 1983.
mouse LD50 subcutaneous 145ug/kg (.145mg/kg) BEHAVIORAL: ATAXIA

SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 11, Pg. 4175, 1983.
rat LD50 intraperitoneal > 5mg/kg (5mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

KIDNEY, URETER, AND BLADDER: OTHER CHANGES

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 11, Pg. 4175, 1983.
rat LD50 intravenous 105ug/kg (.105mg/kg)   Japanese Kokai Tokyo Koho Patents. Vol. #94-247858,
rat LD50 oral 620ug/kg (.62mg/kg)   Japanese Kokai Tokyo Koho Patents. Vol. #94-247858,
rat LD50 subcutaneous 66ug/kg (.066mg/kg)   Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 11, Pg. 4175, 1983.
rat LD50 subcutaneous 66ug/kg (.066mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ATAXIA
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 11, Pg. 4175, 1983.

Or

1.    

dns-mus:fbr 2 µg/L

    CNREA8    Cancer Research. 46 (1986),604.
2.    

scu-rat LD50:66 µg/kg

    YACHDS    Yakuri to Chiryo. Pharmacology and Therapeutics. 11 (1983),4175.
3.    

orl-mus LD50:1350 µg/kg

    YACHDS    Yakuri to Chiryo. Pharmacology and Therapeutics. 11 (1983),4175.
4.    

ipr-mus LD50:1900 µg/kg

    YACHDS    Yakuri to Chiryo. Pharmacology and Therapeutics. 11 (1983),4175.
5.    

scu-mus LD50:145 µg/kg

    YACHDS    Yakuri to Chiryo. Pharmacology and Therapeutics. 11 (1983),4175.

5. Safety information of Calcitriol
A deadly poison by ingestion, intraperitoneal, and subcutaneous routes. Experimental teratogenic and reproductive effects. Mutation data reported. Enhances intestinal calcium transport and bone mineral mobilization. When heated to decomposition it emits acrid smoke and irritating fumes.
Hazard Codes: VeryT+,HarmfulXn
Risk Statements: 26/27/28-63-36/37/38-20/21/22
R26/27/28:Very toxic by inhalation, in contact with skin and if swallowed. 
R63:Possible risk of harm to the unborn child. 
R36/37/38:Irritating to eyes, respiratory system and skin. 
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed.
Safety Statements: 36/37/39-45-36-26
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection. 
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) 
S36:Wear suitable protective clothing. 
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
RIDADR: UN 2811 6.1/PG 1
WGK Germany: 3
RTECS: FZ4645000
F: 8-10-19
HazardClass: 6.1(a)
PackingGroup: I

6. Uses of Calcitriol
Calcitriol is used to manufacture the antineoplastic or antipsoriatic drug. Calcitriol also called 1,25-dihydroxycholecalciferol or 1,25-dihydroxyvitamin D3 is the hormonally active form of vitamin D with three hydroxyl groups (abbreviated 1,25-(OH)2D3 or simply 1,25(OH)2D). It increases the level of calcium (Ca2+) in the blood by increasing the uptake of calcium from the gut into the blood, and possibly increasing the release of calcium into the blood from bone.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View